NASDAQ: ADMP       Adamis Pharmaceuticl
Last Price Today's Change   Day's Range   Trading Volume
0.495   -0.034 (6.43%)  0.451 - 0.542  2,910,546


Avg Volume (4 weeks):6,848,105
4 Weeks Range:0.376 - 0.78
4 Weeks Price Volatility (%):
52 Weeks Range:0.27 - 1.51
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company that develops and commercializes products in the therapeutic areas of respiratory disease and allergy. Adamis pharmaceutical product candidates include the Epinephrine Injection PFS syringe product which is used in the emergency treatment of anaphylaxis, APC-1000 and APC-5000 used for treating asthma and chronic obstructive pulmonary disease, and APC-2000 for treatmenting bronchospasms. Through its subsidiary it also provides prescription compounded medications, including compounded sterile preparations, and nonsterile compounds to patients, physician clinics, hospitals, surgery centers and other clients throughout United States. It also provides certain veterinary pharmaceutical products for animals.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3471  2547  373  3175 

Top 10 Active Counters
 SNDL 0.733+0.081 
 NIO 46.159+0.799 
 LK 1.38+1.38 
 CATB 2.409+0.779 
 NAOV 1.66+0.951 
 BB 7.84+0.84 
 FCEL 7.38-1.67 
 PLTR 22.50-3.17 
 WORK 43.015-0.825 
 NXTD 0.493+0.083